The Journal of Bone and Joint Surgery (American) 83:S7-S14 (2001)
© 2001 The Journal of Bone and Joint Surgery, Inc.
The Crystal Structure of the BMP-2:BMPR-IA Complex and the Generation of BMP-2 Antagonists
Joachim Nickel, PhD,
Matthias K. Dreyer, PhD,
Thomas Kirsch, PhD and
Walter Sebald, PhD
Investigation performed at Physiologische Chemie II, Biozentrum
der Universität Würzburg, Würzburg, Germany
Joachim Nickel, PhD
Matthias K. Dreyer, PhD
Walter Sebald, PhD
Physiologische Chemie II, Biozentrum der Universität Würzburg,
Am Hubland, 97074 Würzburg, Germany. E-mail address for W. Sebald: sebald{at}biozentrum.uni-wuerzburg.de
Thomas Kirsch, PhD
Medigene, Lochhamer Str. 11, 82152 Martinsried, Germany
In support of their research or preparation of this manuscript,
one or more of the authors received grants or outside funding from
Deutsche Forschungsgemeinschaft (DFG) Grant SFB 487 TP B1 and B2.
None of the authors received payments or other benefits or a commitment
or agreement to provide such benefits from a commercial entity.
No commercial entity paid or directed, or agreed to pay or direct,
any benefits to any research fund, foundation, educational institution,
or other charitable or nonprofit organization with which the authors
are affiliated or associated.
Background:
Bone morphogenetic proteins (BMPs) and growth and differentiation
factors (GDFs) belong to the large transforming growth factor-ß
(TGF-ß) superfamily of multifunctional cytokines. Signaling of the
BMPs requires the binding of the BMP to the BMP cell surface receptors
BMPR-IA, BMPR-IB, and BMPR-II. Similar to other cytokines, members of
the TGF-ß superfamily exhibit stringent specificity in their ligand-receptor
interactions, which may be a reason for the qualitative and quantitative
differences in cellular responses. To understand how BMPs and GDFs
activate their receptors, it is important to determine structure
and binding mechanisms of ligand-receptor complexes. We have used BMP-2
as a key representative of the BMPs to identify the epitopes for
type I and type II receptor binding by mutational interaction analyses
and have solved the crystal structure of a BMP-2:BMPR-IA receptor
ectodomain complex.
Methods:
To identify amino acid side chains involved in receptor binding,
a collection of
in vitro
mutagenized human BMP-2 variants was prepared and subjected to
interaction analyses with use of the receptor ectodomains of BMPR-IA,
BMPR-II, and ActR-II immobilized on a biosensor system. The biological
activity of the BMP-2 variants was measured by BMP-2 dependent expression
of alkaline phosphatase (ALP) in C2C12 cells. For crystallization,
a complex of BMP-2 and the ectodomain of BMPR-IA was formed in solution,
purified, and crystallized as described
12
.
Results:
The ligand-receptor interaction analysis of the BMP-2 variants
identified distinct epitopes for type I and type II receptor binding.
Because the structure of TGF-ß-like proteins has been compared with
that of an open hand, the binding epitope for the type I receptor
was-on the basis of its location-termed "wrist" epitope. The crystal
structure of the BMP-2:BMPR-IA ectodomain complex revealed a key feature
of the ligand-receptor interaction: a large hydrophobic residue
(Phe85) within a hydrophobic patch of BMPR-IA fit into a hydrophobic
pocket composed of residues of both BMP-2 monomers. A second epitope
identified by alanine mutagenesis scanning was termed the "knuckle"
epitope on the basis of its location on the outer side of the "finger" segments
of BMP-2. Mutations in either the wrist epitope or the knuckle epitope
produced variants with altered biological activities. Variants with antagonistic
properties were exclusively generated by mutations in the knuckle
epitope of BMP-2.
Conclusions and Clinical Relevance:
The identification and characterization of the two receptor binding
epitopes in BMP-2 provide new insight into the primary steps of
BMP-receptor activation. Because of the structural similarities between
members of the TGF-ß superfamily, it can be assumed that the data
presented in this work are transferable to other TGF-ß receptor
systems. Because of the association with various diseases, the generation
of antagonists of other TGF-ß superfamily members might generate
potent tools for basic research and therapeutic approaches.

CiteULike Connotea Del.icio.us Facebook Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Sun, F.-F. Zhuang, J. E. Mullersman, H. Chen, E. J. Robertson, D. Warburton, Y.-H. Liu, and W. Shi
BMP4 Activation and Secretion Are Negatively Regulated by an Intracellular Gremlin-BMP4 Interaction
J. Biol. Chem.,
September 29, 2006;
281(39):
29349 - 29356.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. W. Cook, T. B. Thompson, S. P. Kurup, T. S. Jardetzky, and T. K. Woodruff
Structural Basis for a Functional Antagonist in the Transforming Growth Factor {beta} Superfamily
J. Biol. Chem.,
December 2, 2005;
280(48):
40177 - 40186.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|